{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T20:15:01Z","timestamp":1767730501326,"version":"build-2238731810"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-025-11249-w","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T13:01:19Z","timestamp":1764594079000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating miRNAs in thyroid cancer: prognostic promise of miR-155 and limitations of miR-429"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7737-795X","authenticated-orcid":false,"given":"Doha R.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7713-5421","authenticated-orcid":false,"given":"Safinaz H.","family":"El-kholany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1693-2932","authenticated-orcid":false,"given":"Maivel H.","family":"Ghattas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8322-2829","authenticated-orcid":false,"given":"Mamdouh","family":"El-Nahas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1852-4374","authenticated-orcid":false,"given":"Noha M.","family":"Abd El-Fadeal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"11249_CR1","volume-title":"StatPearls (Internet)","author":"MA Shahid","year":"2025","unstructured":"Shahid MA, Ashraf MA, Sharma S (2025) Physiology, thyroid hormone. In: StatPearls (Internet). StatPearls Publishing, Treasure Island (FL)."},{"key":"11249_CR2","doi-asserted-by":"crossref","unstructured":"Al-Suhaimi EA, Khan FA (2022) Thyroid glands: physiology and structure. In: Al-Suhaimi EA (ed) Emerging concepts in endocrine structure and functions. Springer Nature Singapore, Singapore, pp 133\u2013160","DOI":"10.1007\/978-981-16-9016-7_5"},{"issue":"1","key":"11249_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","volume":"33","author":"ZW Baloch","year":"2022","unstructured":"Baloch ZW et al (2022) Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol 33(1):27\u201363. https:\/\/doi.org\/10.1007\/s12022-022-09707-3","journal-title":"Endocr Pathol"},{"key":"11249_CR4","doi-asserted-by":"publisher","unstructured":"Coca-Pelaz A et al (2020) Papillary Thyroid Cancer-Aggressive Variants and Impact on Management: A Narrative Review., Adv. Ther.\u00a037(7):3112\u20133128, Jul. https:\/\/doi.org\/10.1007\/s12325-020-01391-1","DOI":"10.1007\/s12325-020-01391-1"},{"key":"11249_CR5","doi-asserted-by":"publisher","unstructured":"Wong KS, Higgins SE, Marqusee E, Nehs MA, Angell T, Barletta JA (2019) Tall cell variant of papillary thyroid carcinoma: impact of change in WHO definition and molecular analysis., Endocr. Pathol.\u00a030(1):43\u201348. https:\/\/doi.org\/10.1007\/s12022-018-9561-4","DOI":"10.1007\/s12022-018-9561-4"},{"key":"11249_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082164","author":"C Nyl\u00e9n","year":"2020","unstructured":"Nyl\u00e9n C et al (2020) Molecular markers guiding thyroid cancer management. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12082164","journal-title":"Cancers (Basel)"},{"issue":"1","key":"11249_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-6676-z","volume":"20","author":"D Wu","year":"2020","unstructured":"Wu D, Hu S, Hou Y, He Y, Liu S (2020) Identification of potential novel biomarkers to differentiate malignant thyroid nodules with cytological indeterminate. BMC Cancer 20(1):199. https:\/\/doi.org\/10.1186\/s12885-020-6676-z","journal-title":"BMC Cancer"},{"key":"11249_CR8","doi-asserted-by":"publisher","unstructured":"Kimura T, [Non-coding Natural, Antisense RNA (2020) Mechanisms of Action in the Regulation of Target Gene Expression and Its Clinical Implications]., Yakugaku Zasshi, vol. 140, no. 5, pp. 687\u2013700. https:\/\/doi.org\/10.1248\/yakushi.20-00002","DOI":"10.1248\/yakushi.20-00002"},{"issue":"1","key":"11249_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/mps4010010","volume":"4","author":"I Dasgupta","year":"2021","unstructured":"Dasgupta I, Chatterjee A (2021) Recent advances in miRNA delivery systems. Methods Protoc 4(1):10. https:\/\/doi.org\/10.3390\/mps4010010","journal-title":"Methods Protoc"},{"key":"11249_CR10","doi-asserted-by":"publisher","unstructured":"Smolarz B, Durczy\u0144ski A, Romanowicz H, Szy\u0142\u0142o K, Hogendorf P (2022) miRNAs in Cancer (Review of Literature)., Int. J. Mol. Sci.\u00a023(5). https:\/\/doi.org\/10.3390\/ijms23052805","DOI":"10.3390\/ijms23052805"},{"key":"11249_CR11","doi-asserted-by":"publisher","DOI":"10.1042\/EBC20200032","author":"H Yan","year":"2021","unstructured":"Yan H, Bu P (2021) Non-coding RNA in cancer. Essays Biochem. https:\/\/doi.org\/10.1042\/EBC20200032","journal-title":"Essays Biochem"},{"issue":"1","key":"11249_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.oraloncology.2014.10.006","volume":"51","author":"YS Lee","year":"2015","unstructured":"Lee YS et al (2015) Differential expression levels of plasma-derived miR-146b and miR-155 in papillary thyroid cancer. Oral Oncol 51(1):77\u201383. https:\/\/doi.org\/10.1016\/j.oraloncology.2014.10.006","journal-title":"Oral Oncol"},{"key":"11249_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040632","author":"J-L Park","year":"2021","unstructured":"Park J-L, Kim S-K, Jeon S, Jung C-K, Kim Y-S (2021) Microrna profile for diagnostic and prognostic biomarkers in thyroid cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13040632","journal-title":"Cancers (Basel)"},{"issue":"3","key":"11249_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ncrna.2020.06.001","volume":"5","author":"S Ghafouri-Fard","year":"2020","unstructured":"Ghafouri-Fard S, Shirvani-Farsani Z, Taheri M (2020) The role of MicroRNAs in the pathogenesis of thyroid cancer. Non-coding RNA Res 5(3):88\u201398. https:\/\/doi.org\/10.1016\/j.ncrna.2020.06.001","journal-title":"Non-coding RNA Res"},{"key":"11249_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18030636","author":"C-K Chou","year":"2017","unstructured":"Chou C-K, Liu R-T, Kang H-Y (2017) MicroRNA-146b: a novel biomarker and therapeutic target for human papillary thyroid cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms18030636","journal-title":"Int J Mol Sci"},{"key":"11249_CR16","doi-asserted-by":"publisher","unstructured":"Mardente S et al (2015) HMGB1-Induced Cross Talk between PTEN and miRs 221\/222 in Thyroid Cancer., Biomed Res. Int., vol. p. 512027, May 2015. https:\/\/doi.org\/10.1155\/2015\/512027","DOI":"10.1155\/2015\/512027"},{"issue":"9","key":"11249_CR17","doi-asserted-by":"publisher","first-page":"11753","DOI":"10.1007\/s13277-016-5030-1","volume":"37","author":"Z Mei","year":"2016","unstructured":"Mei Z et al (2016) Interleukin-22 promotes papillary thyroid cancer cell migration and invasion through microRNA-595\/Sox17 axis. Tumour Biol 37(9):11753\u201311762. https:\/\/doi.org\/10.1007\/s13277-016-5030-1","journal-title":"Tumour Biol"},{"key":"11249_CR18","doi-asserted-by":"publisher","unstructured":"Mahesh G, Biswas R (2019) MicroRNA-155: A Master Regulator of Inflammation.\u00a0J. Interferon Cytokine Res.\u00a039(6):321\u2013330. https:\/\/doi.org\/10.1089\/jir.2018.0155","DOI":"10.1089\/jir.2018.0155"},{"issue":"4","key":"11249_CR19","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.3892\/ijo.2016.3660","volume":"49","author":"K Hua","year":"2016","unstructured":"Hua K et al (2016) Microrna-7 inhibits proliferation, migration and invasion of thyroid papillary cancer cells via targeting CKS2. Int J Oncol 49(4):1531\u20131540. https:\/\/doi.org\/10.3892\/ijo.2016.3660","journal-title":"Int J Oncol"},{"key":"11249_CR20","doi-asserted-by":"publisher","unstructured":"Kan Q, Su Y, Yang H (2017) MicroRNA-335 is downregulated in papillary thyroid cancer and suppresses cancer cell growth, migration and invasion by directly targeting ZEB2., Oncol. Lett., vol. 14, no. 6, pp. 7622\u20137628, Dec. https:\/\/doi.org\/10.3892\/ol.2017.7126","DOI":"10.3892\/ol.2017.7126"},{"key":"11249_CR21","doi-asserted-by":"publisher","unstructured":"Salajegheh A, Vosgha H, Rahman MA, Amin M, Smith RA, Lam AK-Y (May 2016) Interactive role of miR-126 on VEGF-A and progression of papillary and undifferentiated thyroid carcinoma. Hum Pathol 51:75\u201385. https:\/\/doi.org\/10.1016\/j.humpath.2015.12.018","DOI":"10.1016\/j.humpath.2015.12.018"},{"key":"11249_CR22","doi-asserted-by":"publisher","unstructured":"Sun W et al (Jan. 2018) MicroRNA-144 inhibits proliferation by targeting WW domain-containing transcription regulator protein 1 in papillary thyroid cancer. Oncol Lett 15(1):1007\u20131013. https:\/\/doi.org\/10.3892\/ol.2017.7440","DOI":"10.3892\/ol.2017.7440"},{"key":"11249_CR23","doi-asserted-by":"publisher","unstructured":"Guo CM, Liu SQ, Sun MZ (2020) miR-429 as biomarker for diagnosis, treatment and prognosis of cancers and its potential action mechanisms: A systematic literature review.\u00a0Neoplasma.\u00a067(2):215\u2013228. https:\/\/doi.org\/10.4149\/neo_2019_190401N282","DOI":"10.4149\/neo_2019_190401N282"},{"issue":"5","key":"11249_CR24","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1261\/rna.939908","volume":"14","author":"HJ Peltier","year":"2008","unstructured":"Peltier HJ, Latham GJ (2008) Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14(5):844\u2013852. https:\/\/doi.org\/10.1261\/rna.939908","journal-title":"RNA"},{"key":"11249_CR25","doi-asserted-by":"publisher","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method., Methods, vol. 25, no. 4, pp. 402\u2013408, Dec. https:\/\/doi.org\/10.1006\/meth.2001.1262","DOI":"10.1006\/meth.2001.1262"},{"key":"11249_CR26","doi-asserted-by":"publisher","unstructured":"Zhang Y et al (2017) Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma.\u00a0Oncol. Lett.\u00a013(6):4252\u20134266. https:\/\/doi.org\/10.3892\/ol.2017.6028","DOI":"10.3892\/ol.2017.6028"},{"issue":"1","key":"11249_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62534-6","volume":"10","author":"C Cui","year":"2020","unstructured":"Cui C, Cui Q (2020) The relationship of human tissue microRNAs with those from body fluids. Sci Rep 10(1):5644. https:\/\/doi.org\/10.1038\/s41598-020-62534-6","journal-title":"Sci Rep"},{"issue":"10","key":"11249_CR28","first-page":"1364","volume":"36","author":"Y-Z Zhu","year":"2016","unstructured":"Zhu Y-Z et al (2016) Expression of microRNA-155 in papillary thyroid carcinoma and its clinical significance. Nan Fang Yi Ke Da Xue Xue Bao 36(10):1364\u20131368","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"11249_CR29","doi-asserted-by":"publisher","unstructured":"Zhang X et al (2013) Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt\/\u03b2-catenin signaling., J. Clin. Endocrinol. Metab., vol. 98, no. 8, pp. E1305-13, Aug. https:\/\/doi.org\/10.1210\/jc.2012-3602","DOI":"10.1210\/jc.2012-3602"},{"key":"11249_CR30","doi-asserted-by":"publisher","unstructured":"Geng X, Sun Y-Y, Fu J-J, Cao L, Li Y (2020) Role of miR-155-5p expression and its involvement in apoptosis-related factors in thyroid follicular carcinoma., J. Clin. Pharm. Ther.\u00a045(4):660\u2013665. https:\/\/doi.org\/10.1111\/jcpt.13175","DOI":"10.1111\/jcpt.13175"},{"key":"11249_CR31","doi-asserted-by":"publisher","unstructured":"Rezaei M, Khamaneh AM, Zarghami N, Vosoughi A, Hashemzadeh S (2019) Evaluating pre- and post-operation plasma miRNAs of papillary thyroid carcinoma (PTC) patients in comparison to benign nodules., BMC Cancer.\u00a019(1):690. https:\/\/doi.org\/10.1186\/s12885-019-5849-0","DOI":"10.1186\/s12885-019-5849-0"},{"issue":"6","key":"11249_CR32","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1007\/s13304-024-01978-1","volume":"76","author":"M Yigit","year":"2024","unstructured":"Yigit M et al (2024) Investigation of the alterations in miRNA expression levels in thyroid nodules and malignancies. Update Surg 76(6):2329\u20132335. https:\/\/doi.org\/10.1007\/s13304-024-01978-1","journal-title":"Update Surg"},{"issue":"6","key":"11249_CR33","doi-asserted-by":"publisher","first-page":"9016","DOI":"10.1002\/jcb.28173","volume":"120","author":"O Caglar","year":"2019","unstructured":"Caglar O, Cayir A (2019) Total circulating cell-free miRNA in plasma as a predictive biomarker of the thyroid diseases. J Cell Biochem 120(6):9016\u20139022. https:\/\/doi.org\/10.1002\/jcb.28173","journal-title":"J Cell Biochem"},{"issue":"1","key":"11249_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s43042-023-00427-9","volume":"24","author":"G-R Mobini","year":"2023","unstructured":"Mobini G-R, Yousefi H, Shojaeian A, Mirhoseini M, Mahmoudian-Sani M-R (2023) Association of serum miR-375, miR-155 and miR-146b levels with distinguish of papillary thyroid cancer from benign thyroid masses among Iranian patients. Egypt J Med Hum Genet 24(1):48. https:\/\/doi.org\/10.1186\/s43042-023-00427-9","journal-title":"Egypt J Med Hum Genet"},{"key":"11249_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092608","author":"CA Silaghi","year":"2020","unstructured":"Silaghi CA et al (2020) The prognostic value of MicroRNAs in thyroid cancers-a systematic review and meta-analysis. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12092608","journal-title":"Cancers (Basel)"},{"issue":"3","key":"11249_CR36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40291-023-00641-6","volume":"27","author":"Y Wu","year":"2023","unstructured":"Wu Y et al (2023) The diagnostic and prognostic value of miR-155 in cancers: an updated meta-analysis. Mol Diagn Ther 27(3):283\u2013301. https:\/\/doi.org\/10.1007\/s40291-023-00641-6","journal-title":"Mol Diagn Ther"},{"issue":"5","key":"11249_CR37","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ncb1722","volume":"10","author":"PA Gregory","year":"2008","unstructured":"Gregory PA et al (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10(5):593\u2013601. https:\/\/doi.org\/10.1038\/ncb1722","journal-title":"Nat Cell Biol"},{"issue":"3","key":"11249_CR38","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.3892\/ol.2020.11766","volume":"20","author":"L Sun","year":"2020","unstructured":"Sun L, Wang L, Luan S, Jiang Y, Wang Q (2020) Mir-429 inhibits osteosarcoma progression by targeting HOXA9 through suppressing Wnt\/\u03b2-catenin signaling pathway. Oncol Lett 20(3):2447\u20132455. https:\/\/doi.org\/10.3892\/ol.2020.11766","journal-title":"Oncol Lett"},{"key":"11249_CR39","doi-asserted-by":"publisher","unstructured":"Zhang M et al (Mar. 2016) miR-429 functions as a tumor suppressor by targeting FSCN1 in gastric cancer cells. Onco Targets Ther 9:1123\u20131133. https:\/\/doi.org\/10.2147\/OTT.S91879","DOI":"10.2147\/OTT.S91879"},{"issue":"6","key":"11249_CR40","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.kjms.2018.01.001","volume":"34","author":"C-L Wu","year":"2018","unstructured":"Wu C-L, Ho J-Y, Hung S-H, Yu D-S (2018) Mir-429 expression in bladder cancer and its correlation with tumor behavior and clinical outcome. Kaohsiung J Med Sci 34(6):335\u2013340. https:\/\/doi.org\/10.1016\/j.kjms.2018.01.001","journal-title":"Kaohsiung J Med Sci"},{"issue":"1","key":"11249_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12860-022-00420-x","volume":"23","author":"Z Peng","year":"2022","unstructured":"Peng Z, Ouyang X, Wang Y, Fan Q (2022) MAPKAPK5-AS1 drives the progression of hepatocellular carcinoma via regulating miR-429\/ZEB1 axis. BMC Mol Cell Biol 23(1):21. https:\/\/doi.org\/10.1186\/s12860-022-00420-x","journal-title":"BMC Mol Cell Biol"},{"key":"11249_CR42","unstructured":"Han Y, Zhao Q, Zhou J, Shi R 2017. miR-429 mediates tumor growth and metastasis in colorectal cancer. Am J Cancer Res 7(2):218\u2013233"},{"key":"11249_CR43","doi-asserted-by":"publisher","unstructured":"Meng X et al (2015) Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients., Br. J. Cancer..\u00a0113(9):1358\u20131366. https:\/\/doi.org\/10.1038\/bjc.2015.340","DOI":"10.1038\/bjc.2015.340"}],"updated-by":[{"DOI":"10.1007\/s11033-025-11383-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000}}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11249-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11249-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11249-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T06:35:38Z","timestamp":1767508538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11249-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11249"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11249-w","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: In the Results section, the miRNA number was incorrectly published as mir-249. This has now been corrected to mir-429 in several paragraphs and in Figure 4.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11033-025-11383-5","URL":"https:\/\/doi.org\/10.1007\/s11033-025-11383-5","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research was carried out in compliance with the Declaration of Helsinki and its subsequent amendments, ensuring adherence to ethical principles for human research. This study was approved by the ethical research committee of Faculty of Medicine, Port Said University (ERN number: (131) BIC803_001).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written consent was obtained from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable, as no identifiable personal data were included in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"147"}}